Please cite this article in press Dhananjay Narsale et al., Pharmacological Evaluation Of Catechin On Kindling Associated Post-Ictal Depression In Rat, Indo Am. J. P. Sci, 2025; 12(04).

1. APA D. Diagnostic and statistical manual of mental disorders fifth edition. DSM-5. Arlington: Am Psychiatric Publ; 2013.
2. Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord. 2016 Jan 1;189:314-20.
3. Minor KL, Champion JE, Gotlib IH. Stability of DSM-IV criterion symptoms for major depressive disorder. J Psychiatr Res. 2005 Jul 1;39(4):415-20.
4. Kessing LV. Epidemiology of subtypes of depression. Acta Psychiatr Scand. 2007 Feb;115:85-9.
5. Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: implications for clinical practice. Front Psychiatry. 2018 Oct 2;9:412752.
6. Feehan M, McGee R, Raja SN, Williams SM. DSM-III-R disorders in New Zealand 18-year-olds. Aust N Z J Psychiatry. 1994 Jan 1;28(1):87-99.
7. Rohde P, Lewisohn PM, Seeley JR. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol. 1991 May;100(2):214.
8. Power RA, Tansey KE, Buttenschøn HN, Cohen-Woods S, Bigdeli T, Hall LS, et al. Genome-wide association for major depression through age at onset stratification: major depressive disorder working group of the psychiatric genomics consortium. Biol Psychiatry. 2017 Feb 15;81(4):325-35.
9. Verduijn J, Milaneschi Y, Peyrot WJ, Hottenga JJ, Abdellaoui A, de Geus EJ, et al. Using clinical characteristics to identify which patients with major depressive disorder have a higher genetic load for three psychiatric disorders. Biol Psychiatry. 2017 Feb 15;81(4):316-24.
10. Rice F, Riglin L, Lomax T, Souter E, Potter R, Smith DJ, et al. Adolescent and adult differences in major depression symptom profiles. J Affect Disord. 2019 Jan 15;243:175-81.
11. Kovacs M, Akiskal HS, Gatsonis C, Parrone PL. Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome. Arch Gen Psychiatry. 1994 May 1;51(5):365-74.
12. Reddy MV, Chandrashekhar CR. Prevalence of mental and behavioural disorders in India: A meta-analysis. Indian J Psychiatry. 1998;40:149-57.
13. Nandi DN, Banerjee G, Mukherjee SP, Ghosh A, Nandi PS, Nandi S. Psychiatric morbidity of a rural Indian community changes over a 20-year interval. Br J Psychiatry. 2000;176:351-6.
14. Grover S, Dutt A, Avasthi A. An overview of Indian research in depression. Indian J Psychiatry. 2010 Jan 1;52(Suppl1):S178-88.
15. Patel V, Pereira J, Mann AH. Somatic and psychological models of common mental disorder in primary care in India. Psychol Med. 1998;28:135-45.
16. Murray D, Cox JL. Screening for depression during pregnancy with the Edinburgh Depression Scale. J Reprod Infant Psychol. 1990;8:99-107.
17. Miller B, Campbell RT, Farran CJ, Kaufman JE, Davis L. Race, control, mastery, and caregiver distress. J Gerontol B Psychol Sci Soc Sci. 1995;50:S374-82.
18. Flint J, Kendler KS. The genetics of major depression. Neuron. 2014 Feb 5;81(3):484-503.
19. Vandeleur CL, Fassassi S, Castelao E, Glaus J, Strippoli MP, Lasserre AM, et al. Prevalence and correlates of DSM-5 major depressive and related disorders in the community. Psychiatry Res. 2017 Apr 1;250:50-8.
20. Howland R. General health, health care utilization, and medical comorbidity in dysthymia. Int J Psychiatry Med. 2005;23:211-38.
21. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-IIIR major depressive disorder in the general population. Br J Psychiatry. 2006;168:17-30.
22. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 2005;50:85-94.
23. Linde K, Mulrow CD. St. John’s wort for depression. Cochrane Review. The Cochrane Library. 2008.
24. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007 Mar 1;64(3):327-37.
25. Zhang X, Gainetdinov RR, Beaulieu JM, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005;45:11-6.
26. Miyoshi N, Pervin M, Suzuki T, Unno K, Isemura M, Nakamura Y. Green tea catechins for well-being and therapy: Prospects and opportunities. Botanics: Targets Ther. 2015 Dec 9:85-96.
27. Vuong QV, Stathopoulos CE, Nguyen MH, Golding JB, Roach PD. Isolation of green tea catechins and their utilization in the food industry. Food Rev Int. 2011 Jul 1;27(3):227-47.
28. Nuryana I, Ratnakomala S, Fahrurrozi AB, Andriani A, Putra FJ, Rezamela E, et al. Catechin contents, antioxidant and antibacterial activities of different types of Indonesian tea (Camellia sinensis). Ann Bogorienses. 2020;24(2):107.
29. Bae J, Kim N, Shin Y, Kim SY, Kim YJ. Activity of catechins and their applications. Biomed Dermatol. 2020 Dec;4:1-0.
30. Cerbin-Koczorowska M, Waszyk-Nowaczyk M, Bakun P, Goslinski T, Koczorowski T. Current view on green tea catechins formulations, their interactions with selected drugs, and prospective applications for various health conditions. Appl Sci. 2021 May 26;11(11):4905.
31. Meyer BR, White HM, McCormack JD, Niemeyer ED. Catechin composition, phenolic content, and antioxidant properties of commercially-available bagged, gunpowder, and matcha green teas. Plant Foods Hum Nutr. 2023 Dec;78(4):662-9.
32. Tanase C, Coșarcă S, Muntean DL. A critical review of phenolic compounds extracted from the bark of woody vascular plants and their potential biological activity. Molecules. 2019 Mar 26;24(6):1182.
33. Baranwal A, Aggarwal P, Rai A, Kumar N. Pharmacological actions and underlying mechanisms of catechin: A review. Mini Rev Med Chem. 2022 Mar 1;22(5):821-33.
34. Azmi FM, Sockalingam SN, Said MM, Zakaria AS. Clinical applications of catechin in dentistry: A review. J Nat Remedies. 2020 Jan 31:2-15.
35. Latos-Brozio M, Masek A, Piotrowska M. Thermally stable and antimicrobial active poly(catechin) obtained by reaction with a cross-linking agent. Biomolecules. 2020 Dec 31;11(1):50.
36. Leng CS, Hutagalung FD, Li LP. A review of depression and its research studies in Malaysia. Int J Educ. 2017 Jun;2:40-55.
37. Abdullah RB, Rahim MM, Mohammad Asyri MA, Ramza MZ, Geetha C, Musto AE. Glutamate and Epilepsy: An insight from Temporal Lobe Epilepsy. In: Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments. Cham: Springer Int. Publ; 2022 Apr 11. p. 523-37.
38. Syed A, Ali SS, Khan M. Frequency of depression, anxiety, and stress among the undergraduate physiotherapy students. Pak J Med Sci. 2018 Mar;34(2):468.
39. Gul N, Ali A, Umer US, Khan AN, Ghaus SG, Alam S, et al. Isolated hydatid cyst in the right breast. J Rehman Med Inst. 2019 Jul 10;5(2):23-4.
40. Iyer KV, Pulford S, Mogil ner A, Boothby D. Clinical and biological relevance of serotonin transporter genes in psychiatry. Psychiatric Clinics of North America. 2016 Jun 1;39(2):235-49.
41. Fava M, Rush AJ, Trivedi MH, Wisniewski SR, Thase ME, Nierenberg AA, et al. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. J Clin Psychiatry. 2003 Jun;64(6):627-34.
42. Reimherr FW, Hedges D, Paddock S, Glick ID, Potter WZ. A randomized, controlled trial of venlafaxine in major depressive disorder with melancholic features. J Clin Psychiatry. 2003 Jun;64(6):657-64.
43. Luty SE, Carter JD, McKenzie JM, Frampton CM, Mulder RT. A comparison of fluoxetine, nortriptyline, and placebo in the treatment of major depression. Aust N Z J Psychiatry. 2005 Jun;39(6):470-8.
44. Kuehner C. Why is depression more common among women than among men? The Lancet Psychiatry. 2017 Feb;4(2):146-58.
45. Ng RT, Wijesundera HC. Gender differences in the prevalence of depression and anxiety among older adults in New Zealand: Results from a population-based study. Aust N Z J Psychiatry. 2020 Aug;54(8):754-63.
46. Liu X, Guo J, He J, Li W, Liang S, Zhang J. Gender differences in the relationship between perceived stress and depression in a Chinese sample. Psychiatry Res. 2020 Feb 28;285:112785.
47. Durkheim E. Suicide: A Study in Sociology. London: Routledge; 2002.
48. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602.
49. McDermut W, Zimmerman M, Coryell W. A longitudinal study of the relationship between melancholic and non-melancholic depression. J Affect Disord. 2005 Dec;89(1-3):47-52.
50. Linde K, Sigterman K, Taube A, Dvorkin T, Isacsson G, Rees S, et al. A systematic review and meta-analysis of complementary therapies for depression. Cochrane Database Syst Rev. 2015 Mar 26;3:CD011177.
51. Cuijpers P, Karyotaki E, Andersson G. Internet-based interventions for depression and anxiety disorders: A systematic review of the evidence. J Affect Disord. 2020 Oct 1;276:970-80.
52. Parker G, Gladstone G, Chee K. Depression in the human: Evidence of cultural differences. J Affect Disord. 2011 Jan;128(3):213-7.
53. Buist-Bouwman MA, Ormel J, de Graaf R, Vollebergh WA, Alonso J, Angermeyer M, et al. Emotional disorders and disability in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Eur J Psychiatry. 2005;19(3):1-16.
54. Hirschfeld RM, Keller MB, Panico F, Moller HJ. The impact of depression on healthcare utilization and costs: A study of private health plans. J Clin Psychiatry. 2000 Nov;61(11):874-9.
55. Kessler RC, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, Wickramaratne P. Screening for serious mental illness in the general population: The WMH survey initiative. World Psychiatry. 2013 Jun;12(2):170-8.
56. Hohensee C, Brackney DE, Hughes K, Holmes EP. Exploring factors associated with depression among adults with intellectual and developmental disabilities. J Intellect Disabil Res. 2020 Oct;64(10):828-35.
57. Zung WW. The Depression Status Inventory. In: Cleveland M, editor. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 1993. p. 102-8.
58. Böttcher P, Schredl M. Sleep and depression: The role of the serotonin system. Psychiatry Res. 2020 May 30;286:112828.
59. Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in mental health care in the United States. N Engl J Med. 2014 May 8;370(19):1517-25.
60. Zimmerman M, Chelminski I, Posternak MA, Young D, Dalrymple K. Understanding the relationship between major depressive disorder and dysthymic disorder: A study of the overlap. J Clin Psychiatry. 2013 Oct 1;74(10):1010-6.
61. Oquendo MA, Baca-Garcia E, Grushko O, Muneer A, Berman S, Sher L. The neurobiology of suicide and its implications for clinical practice. J Psychiatr Res. 2014 Dec;59:1-14.
62. Fava M, Asnis GM, Zajecka JM. Understanding the pharmacotherapy of major depressive disorder. CNS Spectr. 2014 May;19(5):352-62.
63. Altemus M, Neill E, Pillemer S. Gender differences in the biology of depression. In: Sanguinetti T, editor. Depression and Anxiety: Pathogenesis, Diagnosis, and Treatment. Boca Raton, FL: CRC Press; 2015. p. 121-36.
64. Holtzheimer PE, Mayberg HS. Stuck in a rut: Reconsidering depression and its treatment. Trends in Neurosciences. 2011 Jan;34(1):1-9.
65. Kessing LV, Andersen PK, Mortensen PB. The effect of the level of education on the risk of developing major depression. J Affect Disord. 2002 Dec;71(3):201-8.
66. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care. 2008 Dec;31(12):2398-2408.
67. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month prevalence and lifetime comorbidity of DSM-IV mood and anxiety disorders in the United States. Arch Gen Psychiatry. 2012 Dec;69(12): 1-18.
68. Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001 Oct;62(10):5-11.
69. Lee J, Hahm BJ, Kim S, Lee H, Seo H, Oh K, et al. A study on the epidemiology of major depressive disorder and its treatment. J Korean Med Sci. 2012 Dec;27(12):1594-1600.
70. McKeon AM, Davidson K, Waugh R, McGlinchey E, McDonald K. An investigation into the use of complementary therapies for depression in general practice. J Clin Psychopharmacol. 2006 Aug;26(4):406-12.
71. Jones L, Walters E, Raffaele S, Stein DJ. The relationship between chronic pain and depression in the general population: A cross-sectional study. J Pain. 2008 Oct;9(10):1042-50.
72. Davidson JR. Impact of comorbid depression on the treatment of anxiety disorders. J Clin Psychiatry. 2001 Oct;62(Suppl 18):25-30.
73. Muench J, Hamer AM. Big data and depression: The promise of precision medicine in psychiatry. Dialogues Clin Neurosci. 2018 Mar;20(1):17-23.
74. Baldwin DS, Montgomery SA, O’Connor C, Patel S, Wong EC, Zohar J. Efficacy and safety of agomelatine in major depressive disorder: A systematic review and meta-analysis. Psychopharmacology (Berl). 2016 Aug;233(16):2919-2929.
75. Nusslock R, Miller GE. Endocrine and immune contributions to depression: Implications for treatment. Neurosci Biobehav Rev. 2016 Nov;74:138-156.
76. Bauer M, Glenn T, Glick ID, Hauser P. Antidepressants in the treatment of mood disorders. In: Phelps R, editor. Principles and Practice of Psychopharmacotherapy. New York: Springer; 2014. p. 357-385.
77. Muench J, Schaub MP, Lee S, John C, Jäger R, Finkelstein D, et al. Cognitive behavioral therapy and antidepressant medication in major depressive disorder. Psychiatry Res. 2021 Apr 30;295:113526.
78. Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in mental health care in the United States. N Engl J Med. 2014 May 8;370(19):1517-1525.
79. Wang J, Biederman J, Birmaher B, Tsuang M. Psychiatric comorbidity in children with depression: A prospective study. Am J Psychiatry. 2002 Mar;159(3):291-296.
80. Cleare AJ, Pariante CM, Young AH, et al. The use of antidepressants in depression: Critical considerations and recommendations. The Lancet Psychiatry. 2017 Feb;4(2):124-131.